HILLARY WILT: Open Payments
NPI 1871379156 · SUMTER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,030 in 78 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $964 · 2025 $2,030
Food & beverage: $1,895Education: $135
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $529 |
| GENZYME CORPORATION | 8 | $272 |
| GlaxoSmithKline, LLC. | 13 | $240 |
| Insmed, Inc. | 12 | $229 |
| Regeneron Healthcare Solutions, Inc. | 7 | $221 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| United Therapeutics Corporation | 3 | $87 |
| Philips North America LLC | 4 | $73 |
| UCB, Inc. | 2 | $49 |
| Amgen Inc. | 2 | $45 |
Products named: DUPIXENT, TEZSPIRE, Arikayce, FASENRA, TRELEGY ELLIPTA, AIRSUPRA, NUCALA, Tyvaso.
Industry payments across SC — which companies pay providers there.
